Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


19.03.2018

1 Anatol J Cardiol
1 BMC Pulm Med
1 BMJ Open Respir Res
1 Cardiol Res Cardiovasc Med
1 Circ J
3 Curr Opin Pulm Med
1 ERJ Open Res
2 Eur J Cardiothorac Surg
1 Exp Clin Transplant
1 Front Pharmacol
1 Front Physiol
1 Inflammation
3 Int J Cardiol
1 J Am Coll Nutr
1 J Cardiothorac Vasc Anesth
1 J Med Chem
2 J Mol Cell Cardiol
1 JAMA Cardiol
2 Lancet Respir Med
1 Mol Biol Cell
1 Open Heart
2 Pediatr Nephrol
1 Presse Med
1 Pulm Circ
1 Pulm Pharmacol Ther
1 Respirology
1 Ter Arkh
1 Thromb Res
1 Zhonghua Er Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anatol J Cardiol

  1. SAHIN M, Oguz S, Ozer S, Orem C, et al
    Successful treatment of a renal arteriovenous fistula with pulmonary hypertension occurring 38 years after nephrectomy.
    Anatol J Cardiol. 2018 Mar 13. doi: 10.14744/AnatolJCardiol.2018.65693.
    PubMed     Text format    


    BMC Pulm Med

  2. HARBAUM L, Baaske KM, Simon M, Oqueka T, et al
    Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension.
    BMC Pulm Med. 2017;17:72.
    PubMed     Text format     Abstract available


    BMJ Open Respir Res

  3. YORKE J, Deaton C, Campbell M, McGowen L, et al
    Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study.
    BMJ Open Respir Res. 2018;5:e000263.
    PubMed     Text format     Abstract available


    Cardiol Res Cardiovasc Med

  4. ABOUELNOUR AE, Doyle M, Thompson DV, Yamrozik J, et al
    Does Late Gadolinium Enhancement still have Value? Right Ventricular Internal Mechanical Work, Ea/Emax and Late Gadolinium Enhancement as Prognostic Markers in Patients with Advanced Pulmonary Hypertension via Cardiac MRI.
    Cardiol Res Cardiovasc Med. 2017;2017.
    PubMed     Text format     Abstract available


    Circ J

  5. MIWA H, Tanabe N, Jujo T, Kato F, et al
    Long-Term Outcome of Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center.
    Circ J. 2018 Mar 13. doi: 10.1253/circj.CJ-17-1242.
    PubMed     Text format     Abstract available


    Curr Opin Pulm Med

  6. WEATHERALD J, Chaumais MC, Montani D
    Pulmonary arterial hypertension induced by tyrosine kinase inhibitors.
    Curr Opin Pulm Med. 2017;23:392-397.
    PubMed     Text format     Abstract available

  7. DOUWES JM, Berger RMF
    Pediatric pulmonary arterial hypertension: on the eve of growing up.
    Curr Opin Pulm Med. 2017;23:398-403.
    PubMed     Text format     Abstract available

  8. HUERTAS A, Tu L, Guignabert C
    New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways.
    Curr Opin Pulm Med. 2017;23:377-385.
    PubMed     Text format     Abstract available


    ERJ Open Res

  9. HUANG D, Cheng YY, Chan PH, Hai J, et al
    Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study.
    ERJ Open Res. 2018;4.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  10. CAVIEZEL C, Aruldas C, Franzen D, Ulrich S, et al
    Lung volume reduction surgery in selected patients with emphysema and pulmonary hypertension.
    Eur J Cardiothorac Surg. 2018 Mar 12. pii: 4930722. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. GLORION M, Mercier O, Mitilian D, De Lemos A, et al
    Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension.
    Eur J Cardiothorac Surg. 2018 Mar 8. pii: 4924814. doi: 10.1093.
    PubMed     Text format     Abstract available


    Exp Clin Transplant

  12. CIFTCI O, Akgun NA, Yilmaz KC, Karacaglar E, et al
    Posttransplant Pulmonary Hypertension Is Correlated With Acute Rejection and Death Among Cardiac Transplant Recipients: A Single Center Study.
    Exp Clin Transplant. 2018;16.
    PubMed     Text format     Abstract available


    Front Pharmacol

  13. XIA J, Yang L, Dong L, Niu M, et al
    Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats.
    Front Pharmacol. 2018;9:134.
    PubMed     Text format     Abstract available


    Front Physiol

  14. PI L, Fu C, Lu Y, Zhou J, et al
    Vascular Endothelial Cell-Specific Connective Tissue Growth Factor (CTGF) Is Necessary for Development of Chronic Hypoxia-Induced Pulmonary Hypertension.
    Front Physiol. 2018;9:138.
    PubMed     Text format     Abstract available


    Inflammation

  15. SUN LY, Cai ZY, Pu J, Li J, et al
    5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Inflammation. 2017;40:806-817.
    PubMed     Text format     Abstract available


    Int J Cardiol

  16. AYUBI E, Safiri S
    Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues.
    Int J Cardiol. 2017;249:417.
    PubMed     Text format    

  17. ZHAO J, Wang Y, Wang Q, Li M, et al
    Response to letter "Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues".
    Int J Cardiol. 2017;249:418.
    PubMed     Text format    

  18. CURRIE BJ, Johns C, Chin M, Charalampopolous T, et al
    CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds.
    Int J Cardiol. 2018 Mar 4. pii: S0167-5273(17)36908.
    PubMed     Text format     Abstract available


    J Am Coll Nutr

  19. ZANELLA PB, Avila CC, de Souza CG
    Anthropometric Evaluation and Functional Assessment of Patients with Pulmonary Hypertension and its Relationship with Pulmonary Circulation Parameters and Functional Performance.
    J Am Coll Nutr. 2018 Mar 13:1-6. doi: 10.1080/07315724.2017.1417925.
    PubMed     Text format     Abstract available


    J Cardiothorac Vasc Anesth

  20. GAVRA P, Denault AY, Theoret Y, Perrault LP, et al
    Pharmacokinetics and Pharmacodynamics of Nebulized and Intratracheal Milrinone in a Swine Model of Hypercapnia Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2018 Jan 31. pii: S1053-0770(18)30035.
    PubMed     Text format     Abstract available


    J Med Chem

  21. LE HIRESS M, Akagah B, Bernadat G, Tu L, et al
    Design, Synthesis and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
    J Med Chem. 2018 Mar 10. doi: 10.1021/acs.jmedchem.7b01312.
    PubMed     Text format     Abstract available


    J Mol Cell Cardiol

  22. IKUTOMI M, Minami Y, Sahara M
    Response to "Comment to the article 'Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation'".
    J Mol Cell Cardiol. 2017;103:137-138.
    PubMed     Text format    

  23. YANG JX, Pan YY, Wang XX
    Comments to the article "Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation".
    J Mol Cell Cardiol. 2017;103:139-140.
    PubMed     Text format    


    JAMA Cardiol

  24. VANDERPOOL RR, Saul M, Nouraie M, Gladwin MT, et al
    Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
    JAMA Cardiol. 2018 Mar 14. pii: 2674721. doi: 10.1001/jamacardio.2018.0128.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  25. HOEPER MM
    Combination or monotherapy for pulmonary arterial hypertension?
    Lancet Respir Med. 2016 Feb 26. pii: S2213-2600(16)00058.
    PubMed     Text format    

  26. RATJEN F
    Pulmonary artery hypertension: an underrated disease manifestation in cystic fibrosis?
    Lancet Respir Med. 2016 Jun 9. pii: S2213-2600(16)30107.
    PubMed     Text format    


    Mol Biol Cell

  27. COPELAND CA, Han B, Tiwari A, Austin ED, et al
    A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal.
    Mol Biol Cell. 2017;28:3095-3111.
    PubMed     Text format     Abstract available


    Open Heart

  28. HAN Y, Forfia PR, Vaidya A, Mazurek JA, et al
    Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension.
    Open Heart. 2018;5:e000736.
    PubMed     Text format     Abstract available


    Pediatr Nephrol

  29. HOGAN J, Salomon R, Krid S, Bonnet D, et al
    Pulmonary hypertension in an adolescent with end-stage-renal disease-a diagnostic challenge: Answers.
    Pediatr Nephrol. 2018 Mar 12. pii: 10.1007/s00467-018-3939.
    PubMed     Text format    

  30. HOGAN J, Salomon R, Krid S, Bonnet D, et al
    Pulmonary hypertension in an adolescent with end-stage-renal disease-a diagnostic challenge: Questions.
    Pediatr Nephrol. 2018 Mar 12. pii: 10.1007/s00467-018-3931.
    PubMed     Text format    


    Presse Med

  31. SAVALE L, Chaumais MC, Dorfmuller P, Humbert M, et al
    Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease.
    Presse Med. 2017;46.
    PubMed     Text format    


    Pulm Circ

  32. BAZMPANI MA, Arsos G, Zarogoulidis P, Doumas A, et al
    EXPRESS: A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2018 Jan 1:2045894018768289. doi: 10.1177/2045894018768289.
    PubMed     Text format    


    Pulm Pharmacol Ther

  33. KIMURA G, Kataoka M, Inami T, Fukuda K, et al
    Sorafenib as a potential strategy for refractory pulmonary arterial hypertension.
    Pulm Pharmacol Ther. 2017;44:46-49.
    PubMed     Text format     Abstract available


    Respirology

  34. GOH NSL
    Pulmonary hypertension in combined pulmonary fibrosis and emphysema: A tale of two cities.
    Respirology. 2018 Mar 11. doi: 10.1111/resp.13289.
    PubMed     Text format    


    Ter Arkh

  35. TSAREVA NA, Avdeev SN, Neklyudova GV
    [A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?]
    Ter Arkh. 2017;89:100-103.
    PubMed     Text format     Abstract available


    Thromb Res

  36. PESAVENTO R, Prandoni P
    Prevention and treatment of the chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Mar 2. pii: S0049-3848(18)30264.
    PubMed     Text format     Abstract available


    Zhonghua Er Ke Za Zhi

  37. OLDROYD SH, Bhardwaj A, Pahal P, Sharma S, et al
    [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
    Zhonghua Er Ke Za Zhi. 2018;56:23-28.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: